Welcome to the G-FINDER survey

The G-FINDER survey tracks annual investment into R&D for new products and technologies to address priority global health challenges. This includes basic research and the development of new drugs, vaccines, diagnostics and other tools for global health priorities that disproportionately affect people in low- and middle-income countries, including neglected diseases (NDs)emerging infectious diseases (EIDs) and sexual and reproductive health (SRH) issues.

As part of the ongoing evolution and improvement of the G-FINDER project, we have made the following changes to the survey scope:

Data Tags. The ‘Tag’ feature enriches project details by allowing the addition of one or more tags, for example “paediatric formulation”, “ODA funding” and “antimicrobial resistance”. Choose from our pre-defined options or add customised tags.

Including clinical trial numbers or product names as tags in the format “Clinical trial number: NCT123456” or “Product name: paracetamol” is helpful.  Using this format, including the colon, helps us process your data. 

While optional, adding relevant tags helps us to better understand how your work fits into the global health landscape. You can add unlimited tags to each project.

The G-FINDER project has been funded by the Bill & Melinda Gates Foundation since 2007. Open Philanthropy also supports the project via core funding to Policy Cures Research. For more information, please refer to the frequently asked questions.


Before you start the survey

G-FINDER reports and data portal

Our unique database of R&D investment data for global health issues can be freely accessed through the G-FINDER data portal.

Our analysis and reports based on this data can be found here.

Key dates

14 June 2024
Deadline for completing the survey


0 days left to complete the survey.